Abstract
Original language | English (US) |
---|---|
Pages (from-to) | 796-829 |
Number of pages | 34 |
Journal | The Lancet Gastroenterology & Hepatology |
Volume | 7 |
Issue number | 9 |
DOIs | |
State | Published - Aug 3 2022 |
Bibliographical note
KAUST Repository Item: Exported on 2022-12-15Acknowledgements: Bill & Melinda Gates Foundation.
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet Gastroenterology & Hepatology, Vol. 7, No. 9, 03.08.2022, p. 796-829.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
AU - Sheena, Brittney S
AU - Hiebert, Lindsey
AU - Han, Hannah
AU - Ippolito, Helen
AU - Abbasi-Kangevari, Mohsen
AU - Abbasi-Kangevari, Zeinab
AU - Abbastabar, Hedayat
AU - Abdoli, Amir
AU - Abubaker Ali, Hiwa
AU - Adane, Mesafint Molla
AU - Adegboye, Oyelola A
AU - Adnani, Qorinah Estiningtyas Sakilah
AU - Advani, Shailesh M
AU - Afzal, Muhammad Sohail
AU - Afzal, Saira
AU - Aghaie Meybodi, Mohamad
AU - Ahadinezhad, Bahman
AU - Ahinkorah, Bright Opoku
AU - Ahmad, Sajjad
AU - Ahmad, Tauseef
AU - Ahmadi, Sepideh
AU - Ahmed, Haroon
AU - Ahmed, Muktar Beshir
AU - Ahmed Rashid, Tarik
AU - Akalu, Gizachew Taddesse
AU - Aklilu, Addis
AU - Akram, Tayyaba
AU - Al Hamad, Hanadi
AU - Alahdab, Fares
AU - Alem, Adugnaw Zeleke
AU - Alem, Dejene Tsegaye
AU - Alhalaiqa, Fadwa Alhalaiqa Naji
AU - Alhassan, Robert Kaba
AU - Ali, Liaqat
AU - Ali, Muhammad Ashar
AU - Alimohamadi, Yousef
AU - Alipour, Vahid
AU - Alkhayyat, Motasem
AU - Almustanyir, Sami
AU - Al-Raddadi, Rajaa M
AU - Altawalah, Haya
AU - Amini, Saeed
AU - Amu, Hubert
AU - Ancuceanu, Robert
AU - Andrei, Catalina Liliana
AU - Andrei, Tudorel
AU - Anoushiravani, Amir
AU - Ansar, Adnan
AU - Anyasodor, Anayochukwu Edward
AU - Arabloo, Jalal
AU - Arab-Zozani, Morteza
AU - Argaw, Ayele Mamo
AU - Argaw, Zeleke Gebru
AU - Arshad, Muhammad
AU - Artamonov, Anton A
AU - Ashraf, Tahira
AU - Atlaw, Daniel
AU - Ausloos, Floriane
AU - Ausloos, Marcel
AU - Azadnajafabad, Sina
AU - Azangou-Khyavy, Mohammadreza
AU - Azari Jafari, Amirhossein
AU - Azarian, Ghasem
AU - Bagheri, Sayna
AU - Bahadory, Saeed
AU - Baig, Atif Amin
AU - Banach, Maciej
AU - Barati, Nastaran
AU - Barrow, Amadou
AU - Batiha, Abdul-Monim Mohammad
AU - Bejarano Ramirez, Diana Fernanda
AU - Belgaumi, Uzma Iqbal
AU - Berhie, Alemshet Yirga
AU - Bhagat, Devidas S
AU - Bhardwaj, Nikha
AU - Bhardwaj, Pankaj
AU - Bhattacharyya, Krittika
AU - Bhojaraja, Vijayalakshmi S
AU - Bijani, Ali
AU - Biondi, Antonio
AU - Bodicha, Belay Boda Abule
AU - Bojia, Hunduma Amensisa
AU - Boloor, Archith
AU - Bosetti, Cristina
AU - Braithwaite, Dejana
AU - Briko, Nikolay Ivanovich
AU - Butt, Zahid A
AU - C�mera, Luis Alberto
AU - Chakinala, Raja Chandra
AU - Chakraborty, Promit Ananyo
AU - Charan, Jaykaran
AU - Chen, Shu
AU - Choi, Jee-Young Jasmine
AU - Choudhari, Sonali Gajanan
AU - Chowdhury, Fazle Rabbi
AU - Chu, Dinh-Toi
AU - Chung, Sheng-Chia
AU - Cortesi, Paolo Angelo
AU - Cowie, Benjamin C
AU - Culbreth, Garland T
AU - Dadras, Omid
AU - Dai, Xiaochen
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - De la Hoz, Fernando Pio
AU - Debela, Sisay Abebe
AU - Dedefo, Mohammed Gebre
AU - Demeke, Feleke Mekonnen
AU - Demie, Takele Gezahegn G
AU - Demissie, Getu Debalkie
AU - Derbew Molla, Meseret
AU - Desta, Abebaw Alemayehu
AU - Dhamnetiya, Deepak
AU - Dhimal, Mandira Lamichhane
AU - Dhimal, Meghnath
AU - Didehdar, Mojtaba
AU - Doan, Linh Phuong
AU - Dorostkar, Fariba
AU - Drake, Thomas M
AU - Eghbalian, Fatemeh
AU - Ekholuenetale, Michael
AU - El Sayed, Iman
AU - El Sayed Zaki, Maysaa
AU - Elhadi, Muhammed
AU - Elmonem, Mohamed A
AU - Elsharkawy, Aisha
AU - Enany, Shymaa
AU - Enyew, Daniel Berhanie
AU - Erkhembayar, Ryenchindorj
AU - Eskandarieh, Sharareh
AU - Esmaeilzadeh, Firooz
AU - Ezzikouri, Sayeh
AU - Farrokhpour, Hossein
AU - Fetensa, Getahun
AU - Fischer, Florian
AU - Foroutan, Masoud
AU - Gad, Mohamed M
AU - Gaidhane, Abhay Motiramji
AU - Gaidhane, Shilpa
AU - Galles, Natalie C
AU - Gallus, Silvano
AU - Gebremeskel, Teferi Gebru
AU - Gebreyohannes, Eyob Alemayehu
AU - Ghadiri, Keyghobad
AU - Ghaffari, Kazem
AU - Ghafourifard, Mansour
AU - Ghamari, Seyyed-Hadi
AU - Ghashghaee, Ahmad
AU - Gholami, Ali
AU - Gholizadeh, Abdolmajid
AU - Gilani, Aima
AU - Goel, Amit
AU - Golechha, Mahaveer
AU - Goleij, Pouya
AU - Golinelli, Davide
AU - Gorini, Giuseppe
AU - Goshu, Yitayal Ayalew
AU - Griswold, Max G
AU - Gubari, Mohammed Ibrahim Mohialdeen
AU - Gupta, Bhawna
AU - Gupta, Sapna
AU - Gupta, Veer Bala
AU - Gupta, Vivek Kumar
AU - Haddadi, Rasool
AU - Halwani, Rabih
AU - Hamid, Saeed S
AU - Hamidi, Samer
AU - Hanif, Asif
AU - Haque, Shafiul
AU - Harapan, Harapan
AU - Hargono, Arief
AU - Hariri, Sanam
AU - Hasaballah, Ahmed I
AU - Hasan, S M Mahmudul
AU - Hassanipour, Soheil
AU - Hassankhani, Hadi
AU - Hay, Simon I
AU - Hayat, Khezar
AU - Heidari, Golnaz
AU - Herteliu, Claudiu
AU - Heyi, Demisu Zenbaba
AU - Hezam, Kamal
AU - Holla, Ramesh
AU - Hosseini, Mohammad-Salar
AU - Hosseini, Mostafa
AU - Hosseinzadeh, Mehdi
AU - Hostiuc, Mihaela
AU - Househ, Mowafa
AU - Huang, Junjie
AU - Hussein, Nawfal R
AU - Iavicoli, Ivo
AU - Ibitoye, Segun Emmanuel
AU - Ilesanmi, Olayinka Stephen
AU - Ilic, Irena M
AU - Ilic, Milena D
AU - Irham, Lalu Muhammad
AU - Islam, Jessica Y
AU - Ismail, Nahlah Elkudssiah
AU - Jacobsen, Kathryn H
AU - Jadidi-Niaragh, Farhad
AU - Javadi Mamaghani, Amirreza
AU - Jayaram, Shubha
AU - Jayawardena, Ranil
AU - Jebai, Rime
AU - Jha, Ravi Prakash
AU - Joseph, Nitin
AU - Joukar, Farahnaz
AU - Kaambwa, Billingsley
AU - Kabir, Ali
AU - Kabir, Zubair
AU - Kalhor, Rohollah
AU - Kandel, Himal
AU - Kanko, Tesfaye K Tesfaye
AU - Kantar, Rami S
AU - Karaye, Ibraheem M
AU - Kassa, Bekalu Getnet
AU - Kemp Bohan, Phillip M
AU - Keykhaei, Mohammad
AU - Khader, Yousef Saleh
AU - Khajuria, Himanshu
AU - Khan, Gulfaraz
AU - Khan, Imteyaz A
AU - Khan, Junaid
AU - Khan, Moien AB
AU - Khanali, Javad
AU - Khater, Amir M
AU - Khatib, Mahalaqua Nazli
AU - Khodadost, Mahmoud
AU - Khoja, Abdullah T
AU - Khosravizadeh, Omid
AU - Khubchandani, Jagdish
AU - Kim, Gyu Ri
AU - Kim, Hanna
AU - Kim, Min Seo
AU - Kim, Yun Jin
AU - Kocarnik, Jonathan M
AU - Kolahi, Ali-Asghar
AU - Koteeswaran, Rajasekaran
AU - Kumar, G Anil
AU - La Vecchia, Carlo
AU - Lal, Dharmesh Kumar
AU - Landires, Iv�n
AU - Lasrado, Savita
AU - Lazarus, Jeffrey V
AU - Ledda, Caterina
AU - Lee, Doo Woong
AU - Lee, Sang-woong
AU - Lee, Yeong Yeh
AU - Levi, Miriam
AU - Li, Jiarui
AU - Lim, Stephen S
AU - Lobo, Stany W
AU - Lopukhov, Platon D
AU - Loureiro, Joana A
AU - MacLachlan, Jennifer H
AU - Magdy Abd El Razek, Hassan
AU - Magdy Abd El Razek, Muhammed
AU - Majeed, Azeem
AU - Makki, Alaa
AU - Malekpour, Mohammad-Reza
AU - Malekzadeh, Reza
AU - Malik, Ahmad Azam
AU - Mansour-Ghanaei, Fariborz
AU - Mansournia, Mohammad Ali
AU - Martins-Melo, Francisco Rogerl�ndio
AU - Matthews, Philippa C
AU - Mendoza, Walter
AU - Menezes, Ritesh G
AU - Meretoja, Tuomo J
AU - Mersha, Amanual Getnet
AU - Mestrovic, Tomislav
AU - Miller, Ted R
AU - Minh, Le Huu Nhat
AU - Mirica, Andreea
AU - Mirmoeeni, Seyyedmohammadsadeq
AU - Mirrakhimov, Erkin M
AU - Misra, Sanjeev
AU - Mithra, Prasanna
AU - Moazen, Babak
AU - Mohamadkhani, Ashraf
AU - Mohammadi, Mokhtar
AU - Mohammed, Shafiu
AU - Moka, Nagabhishek
AU - Mokdad, Ali H
AU - Moludi, Jalal
AU - Momtazmanesh, Sara
AU - Monasta, Lorenzo
AU - Moradi, Ghobad
AU - Moradzadeh, Maliheh
AU - Moradzadeh, Rahmatollah
AU - Moraga, Paula
AU - Mostafavi, Ebrahim
AU - Mubarik, Sumaira
AU - Muniyandi, Malaisamy
AU - Murray, Christopher J L
AU - Naghavi, Mohsen
AU - Naimzada, Mukhammad David
AU - Narasimha Swamy, Sreenivas
AU - Natto, Zuhair S
AU - Nayak, Biswa Prakash
AU - Nazari, Javad
AU - Negoi, Ionut
AU - Negru, Serban Mircea
AU - Nejadghaderi, Seyed Aria
AU - Neupane Kandel, Sandhya
AU - Nguyen, Huong Lan Thi
AU - Ngwa, Che Henry
AU - Niazi, Robina Khan
AU - Nnaji, Chukwudi A
AU - Noubiap, Jean Jacques
AU - Nowroozi, Ali
AU - Nu�ez-Samudio, Virginia
AU - Oancea, Bogdan
AU - Ochir, Chimedsuren
AU - Odukoya, Oluwakemi Ololade
AU - Oh, In-Hwan
AU - Olagunju, Andrew T
AU - Olakunde, Babayemi Oluwaseun
AU - Omar Bali, Ahmed
AU - Omer, Emad
AU - Otstavnov, Stanislav S
AU - Oumer, Bilcha
AU - Padubidri, Jagadish Rao
AU - Pana, Adrian
AU - Pandey, Anamika
AU - Park, Eun-Cheol
AU - Pashazadeh Kan, Fatemeh
AU - Patel, Urvish K
AU - Paudel, Uttam
AU - Petcu, Ionela-Roxana
AU - Piracha, Zahra Zahid
AU - Pollok, Richard Charles G
AU - Postma, Maarten J
AU - Pourshams, Akram
AU - Poustchi, Hossein
AU - Rabiee, Mohammad
AU - Rabiee, Navid
AU - Rafiei, Alireza
AU - Rafiei, Sima
AU - Raghuram, Pavan Manibettu
AU - Rahman, Mosiur
AU - Rahmani, Amir Masoud
AU - Rahmawaty, Setyaningrum
AU - Rajesh, Aashish
AU - Ranasinghe, Priyanga
AU - Rao, Chythra R
AU - Rao, Sowmya J
AU - Rashidi, Mahsa
AU - Rashidi, Mohammad-Mahdi
AU - Rawaf, David Laith
AU - Rawaf, Salman
AU - Rawassizadeh, Reza
AU - Rezaei, Negar
AU - Rezapour, Aziz
AU - Rezazadeh-Khadem, Sahba
AU - Rodriguez, Jefferson Antonio Buendia
AU - Rwegerera, Godfrey M
AU - Sabour, Siamak
AU - Saddik, Basema
AU - Saeb, Mohammad Reza
AU - Saeed, Umar
AU - Sahebkar, Amirhossein
AU - Saif-Ur-Rahman, KM
AU - Salahi, Sarvenaz
AU - Salimzadeh, Hamideh
AU - Sampath, Chethan
AU - Samy, Abdallah M
AU - Sanabria, Juan
AU - Sanmarchi, Francesco
AU - Santric-Milicevic, Milena M
AU - Sarveazad, Arash
AU - Sathian, Brijesh
AU - Sawhney, Monika
AU - Seidu, Abdul-Aziz
AU - Sepanlou, Sadaf G
AU - Seylani, Allen
AU - Shahabi, Saeed
AU - Shaikh, Masood Ali
AU - Shaker, Elaheh
AU - Shakhmardanov, Murad Ziyaudinovich
AU - Shannawaz, Mohammed
AU - Shenoy, Suchitra M
AU - Shetty, Jeevan K
AU - Shetty, Pavanchand H
AU - Shibuya, Kenji
AU - Shin, Jae Il
AU - Shobeiri, Parnian
AU - Sibhat, Migbar Mekonnen
AU - Singh, Achintya Dinesh
AU - Singh, Jasvinder A
AU - Singh, Surjit
AU - Skryabin, Valentin Yurievich
AU - Skryabina, Anna Aleksandrovna
AU - Sohrabpour, Amir Ali
AU - Song, Suhang
AU - Tabaeian, Seidamir Pasha
AU - Tadesse, Eyayou Girma
AU - Taheri, Majid
AU - Tampa, Mircea
AU - Tan, Ker-Kan
AU - Tavakoli, Ahmad
AU - Tbakhi, Abdelghani
AU - Tefera, Belay Negash
AU - Tehrani-Banihashemi, Arash
AU - Tesfaw, Habtamu Molla
AU - Thapar, Rekha
AU - Thavamani, Aravind
AU - Tohidast, Seyed Abolfazl
AU - Tollosa, Daniel Nigusse
AU - Tosti, Maria Elena
AU - Tovani-Palone, Marcos Roberto
AU - Traini, Eugenio
AU - Tran, Mai Thi Ngoc
AU - Trihandini, Indang
AU - Tusa, Biruk Shalmeno
AU - Ullah, Irfan
AU - Vacante, Marco
AU - Valadan Tahbaz, Sahel
AU - Valdez, Pascual R
AU - Varthya, Shoban Babu
AU - Vo, Bay
AU - Waheed, Yasir
AU - Weldesenbet, Adisu Birhanu
AU - Woldemariam, Melat
AU - Xu, Suowen
AU - Yahyazadeh Jabbari, Seyed Hossein
AU - Yaseri, Mehdi
AU - Yeshaw, Yigizie
AU - Yi?it, Vahit
AU - Yirdaw, Birhanu Wubale
AU - Yonemoto, Naohiro
AU - Yu, Chuanhua
AU - Yunusa, Ismaeel
AU - Zahir, Mazyar
AU - Zaki, Leila
AU - Zamani, Mohammad
AU - Zamanian, Maryam
AU - Zastrozhin, Mikhail Sergeevich
AU - Vos, Theo
AU - Ward, John W
AU - Dirac, M Ashworth
N1 - KAUST Repository Item: Exported on 2022-12-15 Acknowledgements: Bill & Melinda Gates Foundation.
PY - 2022/8/3
Y1 - 2022/8/3
N2 - Background Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) and Interim Guidance for Country Validation of Viral Hepatitis Elimination (WHO Interim Guidance). We estimated the global, regional, and national prevalence of hepatitis B virus (HBV), as well as mortality and disability-adjusted life-years (DALYs) due to HBV, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. This included estimates for 194 WHO member states, for which we compared our estimates to WHO elimination targets. Methods The primary data sources were population-based serosurveys, claims and hospital discharges, cancer registries, vital registration systems, and published case series. We estimated chronic HBV infection and the burden of HBV-related diseases, defined as an aggregate of cirrhosis due to hepatitis B, liver cancer due to hepatitis B, and acute hepatitis B. We used DisMod-MR 2.1, a Bayesian mixed-effects meta-regression tool, to estimate the prevalence of chronic HBV infection, cirrhosis, and aetiological proportions of cirrhosis. We used mortality-to-incidence ratios modelled with spatiotemporal Gaussian process regression to estimate the incidence of liver cancer. We used the Cause of Death Ensemble modelling (CODEm) model, a tool that selects models and covariates on the basis of out-of-sample performance, to estimate mortality due to cirrhosis, liver cancer, and acute hepatitis B. Findings In 2019, the estimated global, all-age prevalence of chronic HBV infection was 4·1% (95% uncertainty interval [UI] 3·7 to 4·5), corresponding to 316 million (284 to 351) infected people. There was a 31·3% (29·0 to 33·9) decline in all-age prevalence between 1990 and 2019, with a more marked decline of 76·8% (76·2 to 77·5) in prevalence in children younger than 5 years. HBV-related diseases resulted in 555 000 global deaths (487 000 to 630 000) in 2019. The number of HBV-related deaths increased between 1990 and 2019 (by 5·9% [–5·6 to 19·2]) and between 2015 and 2019 (by 2·9% [–5·9 to 11·3]). By contrast, all-age and age-standardised death rates due to HBV-related diseases decreased during these periods. We compared estimates for 2019 in 194 WHO locations to WHO-GHSS 2020 targets, and found that four countries achieved a 10% reduction in deaths, 15 countries achieved a 30% reduction in new cases, and 147 countries achieved a 1% prevalence in children younger than 5 years. As of 2019, 68 of 194 countries had already achieved the 2030 target proposed in WHO Interim Guidance of an all-age HBV-related death rate of four per 100 000. Interpretation The prevalence of chronic HBV infection declined over time, particularly in children younger than 5 years, since the introduction of hepatitis B vaccination. HBV-related death rates also decreased, but HBV-related death counts increased as a result of population growth, ageing, and cohort effects. By 2019, many countries had met the interim seroprevalence target for children younger than 5 years, but few countries had met the WHO-GHSS interim targets for deaths and new cases. Progress according to all indicators must be accelerated to meet 2030 targets, and there are marked disparities in burden and progress across the world. HBV interventions, such as vaccination, testing, and treatment, must be strategically supported and scaled up to achieve elimination.
AB - Background Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) and Interim Guidance for Country Validation of Viral Hepatitis Elimination (WHO Interim Guidance). We estimated the global, regional, and national prevalence of hepatitis B virus (HBV), as well as mortality and disability-adjusted life-years (DALYs) due to HBV, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. This included estimates for 194 WHO member states, for which we compared our estimates to WHO elimination targets. Methods The primary data sources were population-based serosurveys, claims and hospital discharges, cancer registries, vital registration systems, and published case series. We estimated chronic HBV infection and the burden of HBV-related diseases, defined as an aggregate of cirrhosis due to hepatitis B, liver cancer due to hepatitis B, and acute hepatitis B. We used DisMod-MR 2.1, a Bayesian mixed-effects meta-regression tool, to estimate the prevalence of chronic HBV infection, cirrhosis, and aetiological proportions of cirrhosis. We used mortality-to-incidence ratios modelled with spatiotemporal Gaussian process regression to estimate the incidence of liver cancer. We used the Cause of Death Ensemble modelling (CODEm) model, a tool that selects models and covariates on the basis of out-of-sample performance, to estimate mortality due to cirrhosis, liver cancer, and acute hepatitis B. Findings In 2019, the estimated global, all-age prevalence of chronic HBV infection was 4·1% (95% uncertainty interval [UI] 3·7 to 4·5), corresponding to 316 million (284 to 351) infected people. There was a 31·3% (29·0 to 33·9) decline in all-age prevalence between 1990 and 2019, with a more marked decline of 76·8% (76·2 to 77·5) in prevalence in children younger than 5 years. HBV-related diseases resulted in 555 000 global deaths (487 000 to 630 000) in 2019. The number of HBV-related deaths increased between 1990 and 2019 (by 5·9% [–5·6 to 19·2]) and between 2015 and 2019 (by 2·9% [–5·9 to 11·3]). By contrast, all-age and age-standardised death rates due to HBV-related diseases decreased during these periods. We compared estimates for 2019 in 194 WHO locations to WHO-GHSS 2020 targets, and found that four countries achieved a 10% reduction in deaths, 15 countries achieved a 30% reduction in new cases, and 147 countries achieved a 1% prevalence in children younger than 5 years. As of 2019, 68 of 194 countries had already achieved the 2030 target proposed in WHO Interim Guidance of an all-age HBV-related death rate of four per 100 000. Interpretation The prevalence of chronic HBV infection declined over time, particularly in children younger than 5 years, since the introduction of hepatitis B vaccination. HBV-related death rates also decreased, but HBV-related death counts increased as a result of population growth, ageing, and cohort effects. By 2019, many countries had met the interim seroprevalence target for children younger than 5 years, but few countries had met the WHO-GHSS interim targets for deaths and new cases. Progress according to all indicators must be accelerated to meet 2030 targets, and there are marked disparities in burden and progress across the world. HBV interventions, such as vaccination, testing, and treatment, must be strategically supported and scaled up to achieve elimination.
UR - http://hdl.handle.net/10754/686415
UR - https://linkinghub.elsevier.com/retrieve/pii/S2468125322001248
U2 - 10.1016/s2468-1253(22)00124-8
DO - 10.1016/s2468-1253(22)00124-8
M3 - Article
SN - 2468-1253
VL - 7
SP - 796
EP - 829
JO - The Lancet Gastroenterology & Hepatology
JF - The Lancet Gastroenterology & Hepatology
IS - 9
ER -